Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial
Cross, Gail B, Sari, Intan P, Kityo, Cissy, Lu, Qingshu, Pokharkar, Yogesh, Moorakonda, Rajesh B, Thi, Han-Nguyen, Do, Quyet, Dalay, Victoria B, Gutierrez, Emmanuel, Balanag, Vincent M, Castillo, Randy J, Mugerwa, Henry, Fanusi, Felic, Kwan, Philip, Chew, Ka Lip, Paton, Nicholas I, Kityo, Cissy, Mugerwa, Henry, Tumukunde, Dinah, Akol, Joseph, Quyet, Do, Nguyen, Han, Hoang, Xuan Su, Doan, Thu Ha, Dalay, Victoria, Gutierrez, Emmanuel, Balanag, Vincent, Castillo, Randy Joseph, Barcelo, Monica, Veto, Rholine Gem Martin S., Baliwagan, Maria Begonia R., Balane, Glenn, Geronimo, Anthony, Flores, Rupert Rey, Pokharkar, Yogesh, Moorakonda, Rajesh Babu, Lu, Qingshu, Ng, Xuanhui, Tan, Shanice, Paton, Nicholas Iain, Cross, Gail Brenda, Sari, Intan Permata, Chew, Ka Lip, Fanusi, Felic, Kwan, Philip, Kelleher, Anthony Dominic, Chang, Christina
Published in The Lancet infectious diseases (01.07.2023)
Published in The Lancet infectious diseases (01.07.2023)
Get full text
Journal Article